Şunu aradınız:: vidaus ligos (Litvanca - İngilizce)

vidaus ligos
general (internal) medicine

vidaus ligos,
internal medicine

bendroji medicina (vidaus ligos):
general (internal) medicine:

vidaus ligos, įskaitant vaikų ligas
general medicine, including paediatrics

vidaus ligomis
gastrointestinal disorders

lentelėje „bendroji medicina (vidaus ligos)“ ir „oftalmologija“:
in the table on ‘general (internal) medicine’ and ‘ophthalmology’:

nepageidaujamos reakcijos pacientams, sergantiems vidaus ligomis
adverse reactions in medical patients

nepageidaujamas poveikis, pacientams, sergantiems vidaus ligomis
undesirable effects in medical patients

bendrijos vidaus prekybos apribojimai yra neišvengiami siekiant sustabdyti ligą,
the establishment of intra-community trade restrictions is unavoidable in order to control the disease;

-425 vidaus ligomis sergantys pacientai, kuriems buvo tromboembolini komplikacij
-425 medical patients who are at risk for thromboembolic complications treated up to 14 days

trečiosios šalies vidaus ūkis, kuriame taikomos visos būtinos ligų prevencijos priemonės.
an inland farm in a third country subject to all necessary measures to prevent the introduction of diseases.

ypač tai svarbu specialybėms, kurios atsirado iš vidaus ligų arba bendrosios chirurgijos sričių31.
this is of particular relevance to specialities which have grown out of internal medicine or general surgery31.

veninės tromboembolijos (vte) profilaktika vidaus ligomis sergantiems pacientams, kuriems ini
7 prevention of venous thromboembolic events (vte) in medical patients who are at high risk for thromboembolic complications due to restricted mobility during acute illness in a randomised double-blind clinical trial, 839 patients were treated with fondaparinux 2.5 mg once daily or placebo for 6 to 14 days.

4.4 dėl es plėtros ir vidaus rinkos kyla didesnis pavojus ligoms išplisti didesnėje teritorijoje.
4.4 the enlargement of the eu and the internal market has brought with it an increased risk of disease outbreaks over larger areas.

reg klases mazjancio sunkumo tvarka ir sie nepageidaujami poveikiai turt bti interpretuojami atsizvelgiant chirurgines bei vidaus lig aplinkybes.
ho uncommon:1/1,000 to 1/100; rare:1/10,000 to 1/1,000; very rare 1/10,000) and system organ class by decreasing order of seriousness; these adverse reactions should be interpreted within the surgical and medical context.

reg klases mažėjančio sunkumo tvarka ir šie nepageidaujami poveikiai turėtų būti interpretuojami atsižvelgiant į chirurgines bei vidaus ligų aplinkybes.
ho uncommon: ≥ 1/ 1,000 to ≤ 1/ 100; rare: ≥ 1/ 10,000 to ≤ 1/ 1,000; very rare ≤ 1/ 10,000) and system organ class by decreasing order of seriousness; these adverse reactions should be interpreted within the surgical and medical context.

kadangi šiomis sąlygomis būtina prisidėti, kad būtų sukurta vidaus rinka, stengiantis išvengti infekcinių arba užkrečiamųjų ligų;
whereas in this context it is necessary to contribute to the completion of the internal market, avoiding the spread of infectious or contagious diseases;

yra didelis tromboembolinių komplikacijų išsivystymo pavojus ir kurių judėjimas apribotas dėl ūminės ligos klinikinio dvigubai aklu metodu atlikto atsitiktinių imčių tyrimo metu 839 vidaus ligomis sergantys ist
this study included acutely ill medical patients, aged ≥ 60 years, expected to require bed rest for at least four days, and hospitalized for congestive heart failure nyha class iii/ iv and/ or acute respiratory illness and/ or acute infectious or inflammatory disease.

venins tromboembolijos (vte) profilaktika vidaus ligomis sergantiems pacientams, kuriems iniyra didelis tromboembolini komplikacij issivystymo pavojus ir kuri judjimas apribotas dl mins ligos klinikinio dvigubai aklu metodu atlikto atsitiktini imci tyrimo metu 839 vidaus ligomis sergantys ist
7 prevention of venous thromboembolic events (vte) in medical patients who are at high risk for thromboembolic complications due to restricted mobility during acute illness in a randomised double-blind clinical trial, 839 patients were treated with fondaparinux 2.5 mg once daily or placebo for 6 to 14 days.this study included acutely ill medical patients, aged 60 years, expected to require bed rest for at least four days, and hospitalized for congestive heart failure nyha class iii/iv and/or acute respiratory illness and/or acute infectious or inflammatory disease.

vidaus ligomis sergantys pacientai klinikini tyrim metu gydyti 6-14 dien (zr.5. 1 skyri) .
a treatment duration of 6-14 days has been clinically studied in medical patients (see section 5.1) .